Public Contracts Scotland

NP Generic Medicines Transition Tender (October 2023)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Awarded
supplies
Framework agreement
Scotland
4 lots

This tender has closed

The submission deadline for this contract has passed. There may be more active supplies tenders from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"), and hundreds more across the UK public sector.

Key details

Region
Edinburgh
Contract value
£4,972,000ex VAT
Submissions closed
14 August 2023
Published
13 July 2023

Procurement

Submission method
Electronic Submission
Procedure type
Open procedure
CPV classifications
  • 33600000 Pharmaceutical products

What happened

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded this contract to Glenmark Pharmaceuticals Europe Ltd worth £161,316 on 26 Sept 2023.

Description

This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into four (4) individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.

Full description

Supply of Apixaban tablets in a range of presentations.

The Authority intends awarding each product line as a multi-supplier unranked framework agreement to an envisaged maximum of seven (7) suppliers awarded to each line.

Start Date: 01/10/2023

End Date: 30/04/2025

Full details of Goods and volumes can be found within the ITT.

Additional information

The estimated values referred to in Section II.1.5 and each Lot section of this Notice cover the forecasted spend for the duration of each individual Framework Agreement.

The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 24713. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343

A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363

Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/

A summary of the expected community benefits has been provided as follows:

It is a mandatory requirement that potential framework participants agree to support the concept, provision and ongoing development of community benefits provision in relation to this framework.

Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a brief summary of the community benefits that have recently been delivered within Scotland, if at all, and also what impact and outcomes these have achieved.

Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this contract if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits.

For further information please visit NHSS Community Benefit Gateway

(https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/).

Awarded supplier

Supplier
Glenmark Pharmaceuticals Europe Ltd
Award value
£161,316
Award date
26 September 2023

Contact

Address
Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, EH12 9EB

Bid documents

Sign up free to open bid documents and download specifications directly.

Identifiers

Notice ID
rls-57-JUL483793
OCID
ocds-r6ebe6-0000738823

Explore related tenders

External ID: pcs-ocds-r6ebe6-0000738823 • Added 27 May 2026